옵션 체인은 다양한 행사가격과 만기일에 대한 Virax Biolabs Group의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Virax Biolabs Group에 대한 시장 심리를 평가합니다..

Virax Biolabs Group (NASDAQ:VRAX) 주식, 옵션 체인

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Broad U.S. Equity ETFs

Exclusives

Tech

Trading Ideas

ETFs

AAPL

AMZN

APDN

ASTS

CING

CRWD

GOVX

INDO

LUMN

LUNR

NVDA

PLTR

SERV

SMCI

TSLA

VRAX

ZAPP

매일의 거래일에는 트레이더들이 전체 시장과 개별 종목들에 대한 최신 뉴스를 볼 수 있는 소스인 Benzinga Pro에 수백 개의 헤드라인과 보도 자료가 제공된다. 2024년 8월 한 달 동안 Benzinga Pro에서 가장 많이 검색된 주식을 살펴보자. 현재 가격과 연간 실적은 8월 30일을 기준으로 하며 배당금은 포함되지 않았다. 4월 검색결과는 추적되지 않았다.

단독: 2024년 8월 벤징가 프로에서 가장 검색량이 많았던 상위 20개 티커는?

Virax Biolabs Group Limited - Ordinary Shares

Virax Biolabs Group Ltd

Barrington Research analyst Alexander Paris maintains Stride (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) with a Outperform and maintains $140 price target.

News

Price Target

Analyst Ratings

Barrington Research Maintains Outperform on Stride, Maintains $140 Price Target

Loop Capital analyst Alton Stump upgrades Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) from Hold to Buy and raises the price target from $58 to $65.

Upgrades

Loop Capital Upgrades Chipotle Mexican Grill to Buy, Raises Price Target to $65

WestPark Capital analyst Casey Ryan reiterates WM Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAPS#NASDAQ">MAPS</a>) with a Buy and maintains $2.61 price target.

Reiteration

MAPS

WestPark Capital Reiterates Buy on WM Tech, Maintains $2.61 Price Target

On CNBC's &#8220;<a href="https://www.benzinga.com/topic/mad-money-lightning-round">Mad Money Lightning Round,</a>&#8220; Jim Cramer recommended selling NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>).
On March 7, NANO Nuclear Energy announced that Florent Heidet, Ph.D. has joined NANO Nuclear as its Chief Technology Officer and Head of <a href="https://www.benzinga.com/quote/NNE/news">Reactor Development</a>.
Cramer said Illumina, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>) is a &#8220;challenged&#8221; company, and he doesn't really care for it.
RBC Capital analyst Conor McNamara, on March 12, maintained Illumina with an Outperform and lowered the price target from $247 to $128.
When asked about Archer Aviation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>), he said, &#8220;Keep looking but do not press the button.&#8221;
As per the recent news, Archer Aviation and Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), on March 13, collaborated to build the AI foundation for the future of advanced aviation technologies.
The Mad Money host said he has always liked STERIS plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STE#NYSE">STE</a>) and recommended buying the stock. &#8220;I think it's just a strong company,&#8221; he added.
Supporting his view, Stephens &amp; Co. analyst Jacob Johnson, on Feb. 6, reiterated Steris with an Overweight rating and maintained a $240 price target.
Cramer said he doesn't know what Sixth Street Specialty Lending, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSLX#NYSE">TSLX</a>) really owns, so therefore he can't give his opinion on it.
RBC Capital analyst Kenneth Lee, on Feb. 26, maintained Sixth Street Specialty with an Outperform rating and raised the price target from $23 to $25.
Cramer said he likes Lam Research Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) very much and recommended to own the stock.
Adding support to his choice, Susquehanna analyst Mehdi Hosseini, on Feb. 20, upgraded Lam Research from Neutral to Positive and raised the price target from $75 to $125.
Arista Networks Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) has been an &#8220;amazing stock for many years,&#8221; Cramer said. He recommended buying the stock.
Supporting his view, UBS analyst David Vogt, on March 5, upgraded Arista Networks from Neutral to Buy and raised the price target from $112 to $115.
Price Action:
<ul>
<li>Illumina shares fell 0.2% to settle at $84.05 on Thursday.</li>
<li>Archer Aviation shares dipped 3.1% to close at $7.25 during the session.</li>
<li>NANO Nuclear Energy shares gained 1.9% to settle at $28.32.</li>
<li>Steris shares fell 0.9% to close at $222.45.</li>
<li>Sixth Street Specialty Lending shares fell 0.9% to close at $21.96 on Thursday.</li>
<li>Lam Research shares fell 1.7% to settle at $75.26.</li>
<li>Arista Networks shares fell 0.1% to close at $80.14 on Thursday.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44298504/top-3-health-care-stocks-youll-regret-missing-this-quarter">Top 3 Health Care Stocks You&#8217;ll Regret Missing This Quarter</a></li>
</ul>
Image: Shutterstock

Markets

Media

ACHR

ANET

ILMN

LRCX

TSLX

Jim Cramer Says Illumina Is 'Challenged,' Recommends Selling This Industrial Stock

HC Wainwright &amp; Co. analyst Andrew Fein maintains ProQR Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRQR#NASDAQ">PRQR</a>) with a Buy and raises the price target from $10 to $12.

PRQR

HC Wainwright & Co. Maintains Buy on ProQR Therapeutics, Raises Price Target to $12

Morgan Stanley analyst Matthew Harrison maintains 2seventy bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSVT#NASDAQ">TSVT</a>) with a Equal-Weight and lowers the price target from $6 to $5.

TSVT

Morgan Stanley Maintains Equal-Weight on 2seventy bio, Lowers Price Target to $5

Tigress Financial analyst Ivan Feinseth maintains Airbnb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) with a Buy and raises the price target from $195 to $200.

ABNB

Tigress Financial Maintains Buy on Airbnb, Raises Price Target to $200

Morgan Stanley analyst Judah Frommer maintains Regenxbio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGNX#NASDAQ">RGNX</a>) with a Overweight and raises the price target from $22 to $24.

RGNX

Morgan Stanley Maintains Overweight on Regenxbio, Raises Price Target to $24

Jefferies analyst Randal Konik upgrades Revolve Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVLV#NYSE">RVLV</a>) from Hold to Buy and announces $30 price target.

RVLV

Jefferies Upgrades Revolve Gr to Buy, Announces $30 Price Target

U.S. stock futures were higher this morning, with the Dow futures gaining around 150 points on Friday.
Shares of Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) fell sharply in today's pre-market trading after the company reported <a href="https://www.benzinga.com/quote/LI/earnings">fourth-quarter results.</a>
Li Auto posted quarterly adjusted EPADS of 52 cents, up from 30 cents in the year-ago period. The company's sales rose to $6.07 billion from $5.88 billion.
Li Auto shares dipped 5% to $27.30 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Xponential Fitness, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPOF#NYSE">XPOF</a>) shares fell 30.8% to $8.39 in pre-market trading after the company announced fourth-quarter results.</li>
<li>Olema Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLMA#NASDAQ">OLMA</a>) dipped 15.1% to $3.71 in pre-market trading.</li>
<li>CorMedix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMD#NASDAQ">CRMD</a>) declined 8.5% to $9.50 in pre-market trading. Leerink Partners, last week, initiated coverage on the stock with an Outperform rating on the stock and announced an $18 price target.</li>
<li>SI-BONE, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIBN#NASDAQ">SIBN</a>) fell 8.2% to $13.51 in pre-market trading. SI-BONE recently reported better-than-expected fourth-quarter EPS results and issued FY25 sales guidance above estimates.</li>
<li>XPeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) shares dipped 5.4% to $23.99 in pre-market trading. XPeng recenty announced to spend up to $13.8 billion on humanoid robots.</li>
<li>Grupo Supervielle S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUPV#NYSE">SUPV</a>) fell 4.3% to $12.56 in pre-market trading following a 4% decline on Thursday.</li>
<li>EyePoint Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYPT#NASDAQ">EYPT</a>) declined 4.1% to $6.55 in pre-market trading after dipping around 7% on Thursday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44323490/ulta-beauty-docusign-and-3-stocks-to-watch-heading-into-friday">Ulta Beauty, DocuSign And 3 Stocks To Watch Heading Into Friday</a></li>
</ul>

Pre-Market Outlook

Movers

CRMD

EYPT

OLMA

SIBN

SUPV

XPEV

XPOF

Li Auto, Xponential Fitness And Other Big Stocks Moving Lower In Friday's Pre-Market Session

B of A Securities analyst Travis Steed initiates coverage on Penumbra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEN#NYSE">PEN</a>) with a Buy rating and announces Price Target of $320.

Initiation

B of A Securities Initiates Coverage On Penumbra with Buy Rating, Announces Price Target of $320

WIIM

FUTU

Futu Holdings shares are trading higher after the company reported better-than-expected Q4 financial results.

Jefferies analyst Glen Santangelo initiates coverage on ANI Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANIP#NASDAQ">ANIP</a>) with a Buy rating and announces Price Target of $80.

ANIP

Jefferies Initiates Coverage On ANI Pharmaceuticals with Buy Rating, Announces Price Target of $80

<h3>Gainers</h3>
<ul>
<li>MEDIROM Healthcare Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRM#NASDAQ">MRM</a>) stock increased by 35.5% to $0.84 during Friday's pre-market session. The company's market cap stands at $6.6 million. </li>
<li>Solo Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DTC#NYSE">DTC</a>) shares moved upwards by 13.63% to $0.25. The company's market cap stands at $14.6 million. As per the news, the Q4 earnings report came out 2 days ago. </li>
<li>Xcel Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) stock moved upwards by 11.92% to $0.3. The company's market cap stands at $7.2 million. </li>
<li>Cango (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CANG#NYSE">CANG</a>) shares rose 11.81% to $3.69. The market value of their outstanding shares is at $385.1 million. </li>
<li>Foresight Autonomous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSX#NASDAQ">FRSX</a>) stock rose 10.95% to $0.81. The market value of their outstanding shares is at $12.4 million. </li>
<li>SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) stock moved upwards by 10.37% to $0.4. The company's market cap stands at $2.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Xponential Fitness (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPOF#NYSE">XPOF</a>) shares declined by 26.7% to $8.88 during Friday's pre-market session. The company's market cap stands at $286.7 million. The company's, Q4 earnings came out yesterday. </li>
<li>Linkage Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGCB#NASDAQ">LGCB</a>) stock fell 24.79% to $0.17. The company's market cap stands at $5.2 million. </li>
<li>Jiuzi Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZXN#NASDAQ">JZXN</a>) stock decreased by 16.02% to $3.67. The company's market cap stands at $40.4 million. </li>
<li>Worksport (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKSP#NASDAQ">WKSP</a>) shares decreased by 12.65% to $0.49. The market value of their outstanding shares is at $16.1 million. </li>
<li>GrowGeneration (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) stock fell 11.62% to $0.86. The market value of their outstanding shares is at $50.9 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Tilly's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) stock declined by 9.47% to $2.39. The company's market cap stands at $72.0 million. The company's, Q4 earnings came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CANG

FRSX

GRWG

JZXN

LGCB

SBET

TLYS

WKSP

XELB

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>NIP Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIPG#NASDAQ">NIPG</a>) shares rose 17.0% to $1.17 during Friday's pre-market session. The market value of their outstanding shares is at $65.7 million. </li>
<li>BuzzFeed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZFD#NASDAQ">BZFD</a>) stock rose 14.79% to $2.25. The company's market cap stands at $85.5 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>QMMM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMMM#NASDAQ">QMMM</a>) shares rose 13.98% to $1.71. The company's market cap stands at $29.4 million. </li>
<li>Lions Gate Enter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LGF#NYSE">LGF</a>) shares rose 12.45% to $10.29. The market value of their outstanding shares is at $2.4 billion. </li>
<li>Thryv Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRY#NASDAQ">THRY</a>) stock increased by 11.99% to $16.99. The company's market cap stands at $736.8 million. </li>
<li>Baosheng Media Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAOS#NASDAQ">BAOS</a>) stock rose 11.9% to $2.35. The company's market cap stands at $3.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Pop Culture Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPOP#NASDAQ">CPOP</a>) stock fell 11.3% to $0.58 during Friday's pre-market session. The market value of their outstanding shares is at $8.6 million. </li>
<li>Skillz (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKLZ#NYSE">SKLZ</a>) stock fell 9.79% to $4.61. The company's market cap stands at $77.8 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>EPWK Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPWK#NASDAQ">EPWK</a>) shares declined by 8.43% to $4.35. The company's market cap stands at $97.0 million. </li>
<li>Lytus Technologies Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYT#NASDAQ">LYT</a>) stock fell 7.36% to $0.13. The market value of their outstanding shares is at $2.9 million. </li>
<li>Entravision Comms (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVC#NYSE">EVC</a>) stock declined by 6.81% to $1.78. The company's market cap stands at $161.9 million. </li>
<li>DouYu Intl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOYU#NASDAQ">DOYU</a>) shares declined by 5.78% to $7.5. The company's market cap stands at $237.2 million. As per the press release, Q4 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BAOS

BZFD

CPOP

DOYU

EPWK

NIPG

QMMM

SKLZ

THRY

12 Communication Services Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Cellectis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLLS#NASDAQ">CLLS</a>) shares moved upwards by 17.1% to $1.51 during Friday's pre-market session. The company's market cap stands at $151.1 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Iridex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRIX#NASDAQ">IRIX</a>) stock rose 15.46% to $1.12. The company's market cap stands at $18.6 million. </li>
<li>Eton Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETON#NASDAQ">ETON</a>) stock increased by 14.72% to $16.75. The company's market cap stands at $436.3 million. </li>
<li>Nektar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTR#NASDAQ">NKTR</a>) stock rose 11.64% to $0.91. The company's market cap stands at $167.9 million. The company's, Q4 earnings came out 2 days ago. </li>
<li>Adagio Medical Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADGM#NASDAQ">ADGM</a>) stock rose 10.67% to $1.14. The market value of their outstanding shares is at $17.5 million. </li>
<li>Revelation Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REVB#NASDAQ">REVB</a>) stock rose 10.09% to $3.6. The company's market cap stands at $3.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Shuttle Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHPH#NASDAQ">SHPH</a>) stock declined by 25.6% to $0.32 during Friday's pre-market session. The company's market cap stands at $1.5 million. </li>
<li>AirSculpt Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRS#NASDAQ">AIRS</a>) shares decreased by 16.33% to $2.46. The company's market cap stands at $142.3 million. The company's, Q4 earnings came out today. </li>
<li>Sutro Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRO#NASDAQ">STRO</a>) stock fell 16.0% to $1.05. The company's market cap stands at $86.5 million. </li>
<li>Sera Prognostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERA#NASDAQ">SERA</a>) stock decreased by 15.49% to $3.41. The market value of their outstanding shares is at $119.4 million. </li>
<li>Olema Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLMA#NASDAQ">OLMA</a>) shares decreased by 15.34% to $3.7. The company's market cap stands at $274.7 million. </li>
<li>Marker Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRKR#NASDAQ">MRKR</a>) stock decreased by 15.26% to $1.0. The market value of their outstanding shares is at $10.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADGM

AIRS

CLLS

ETON

IRIX

MRKR

NKTR

REVB

SERA

SHPH

STRO

12 Health Care Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) shares rose 19.2% to $15.22 during Friday's pre-market session. The company's market cap stands at $1.4 billion. </li>
<li>Lucas GC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGCL#NASDAQ">LGCL</a>) shares rose 14.96% to $0.7. The market value of their outstanding shares is at $55.6 million. </li>
<li>Lichen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICN#NASDAQ">LICN</a>) stock rose 10.11% to $4.79. The company's market cap stands at $2.8 million. </li>
<li>Satellogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATL#NASDAQ">SATL</a>) shares rose 8.6% to $3.66. The company's market cap stands at $353.6 million. </li>
<li>Huachen AI Parking Mgmt (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCAI#NASDAQ">HCAI</a>) shares moved upwards by 8.52% to $7.0. The market value of their outstanding shares is at $220.4 million. </li>
<li>Hong Kong Pharma Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HKPD#NASDAQ">HKPD</a>) stock moved upwards by 8.25% to $1.28. The market value of their outstanding shares is at $14.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) shares declined by 8.0% to $0.14 during Friday's pre-market session. The market value of their outstanding shares is at $18.3 million. </li>
<li>PS International Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSIG#NASDAQ">PSIG</a>) stock fell 7.2% to $0.45. The market value of their outstanding shares is at $10.9 million. </li>
<li>Icon Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICON#NASDAQ">ICON</a>) shares decreased by 6.77% to $0.13. The company's market cap stands at $3.6 million. </li>
<li>Genpact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) stock decreased by 6.35% to $46.22. The company's market cap stands at $8.1 billion. </li>
<li>American Rebel Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AREB#NASDAQ">AREB</a>) stock decreased by 6.2% to $0.2. </li>
<li>Nuvve Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVVE#NASDAQ">NVVE</a>) shares fell 6.1% to $1.54. The market value of their outstanding shares is at $1.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AREB

HCAI

HKPD

ICON

LGCL

LICN

NVVE

PSIG

SATL

12 Industrials Stocks Moving In Friday's Pre-Market Session

ULTA

Ulta Beauty shares are trading higher after the company reported better-than-expected Q4 financial results.

B of A Securities analyst Christopher Nardone maintains American Eagle Outfitters (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>) with a Neutral and lowers the price target from $18 to $13.

B of A Securities Maintains Neutral on American Eagle Outfitters, Lowers Price Target to $13

Guidance

American Vanguard Corporation Sees FY25 Revenues Between $565M-$585M Vs. $585M Estimate

Contracts

Press Releases

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Healthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Comments

Virax Biolabs Group

Virax Biolabs Group (VRAX) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌